Executive Oncology GU Clinical Development Leader (Hybrid)

GlaxoSmithKline; Upper Providence (Delaware County); Hybride; USD 120 000 - 200 000; Plein temps

Résumé du poste

GlaxoSmithKline is seeking a Clinical Development Lead (CDL) for Oncology GU to shape asset-level strategy and drive development speed. You will partner with MDT, lead governance, and translate data into portfolio decisions, with a focus on integrated strategy across development, regulatory, and commercial readiness.

The role requires MD/PhD-level credentials with 10+ years in oncology clinical development, and a strong track record in governance, leadership, and AI-enabled insights.

Qualifications

• MD/PhD-level clinical expertise with oncology focus.
• Experience leading clinical development strategy and governance.
• Strong data analytics and decision-making capabilities.

Responsabilités

• Define and own asset-wide clinical strategy and narrative.
• Lead or co-lead governance and investment discussions to inform portfolio decisions.
• Mentor Senior Scientists and clinical teams within the CDL programme.
• Engage Health Authorities and cross-functional partners to align on strategy.

Connaissances

Clinical strategy

Governance

Oncology

Data analytics

Leadership

Formation

MD, PharmD, PhD or equivalent

Description du poste

GlaxoSmithKline is seeking a Clinical Development Lead (CDL) for Oncology GU to shape asset-level strategy and drive development speed. You will partner with MDT, lead governance, and translate data into portfolio decisions, with a focus on integrated strategy across development, regulatory, and commercial readiness.

The role requires MD/PhD-level credentials with 10+ years in oncology clinical development, and a strong track record in governance, leadership, and AI-enabled insights.